The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time.
Open Access
- 1 November 1979
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 8 (5), 483-489
- https://doi.org/10.1111/j.1365-2125.1979.tb01031.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLINThe Lancet, 1978
- Evaluation of the thrombo-resistant properties of arterial grafts in an artificial circulationThrombosis Research, 1978
- Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandinBiochemical and Biophysical Research Communications, 1977
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- Are agents affecting platelet functions clinically useful?American Journal Of Medicine, 1976
- Antiplatelet drugs — A new pharmacologic approach to the prevention of thrombosisAmerican Heart Journal, 1976
- Platelet Factor 4 and Adenosine Diphosphate Release during Human Platelet AggregationNature, 1969
- THE EFFECT OF ACETYLSALICYLIC ACID ON PLATELET FUNCTIONThe Journal of Experimental Medicine, 1968
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962